1 month Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus Zacks

XENE reports a narrower-than-expected third-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

Pharmaceuticals

1 month Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus Zacks

4 hours Mirum Pharmaceuticals: Buy At Dips For Volixibat Potential Seeking Alpha

4 hours Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? Zacks

20 hours Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

23 hours Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

2 days Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

2 days Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

2 days Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

2 days Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

2 days Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

4 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

4 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

5 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

5 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

5 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

5 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

5 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

5 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

5 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

6 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

6 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

1 week Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

1 week REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

1 week Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

1 week Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 week SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

1 week Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com

1 week Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

1 week 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

1 week Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

1 week Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

1 week Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

1 week Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

2 weeks Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

2 weeks Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

2 weeks Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

2 weeks Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

2 weeks Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

2 weeks How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

2 weeks Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

2 weeks Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

2 weeks Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

2 weeks Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks

2 weeks Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks

2 weeks BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha

2 weeks Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily

2 weeks Catalyst Pharmaceuticals: Agamree Is Its Key To A Sustainable Future Seeking Alpha

3 weeks Rhythm Pharmaceuticals: A Key Year Ahead Seeking Alpha

The Stock Market News